Mobile Menu

Search Results

Search results for: Healthcare

Drug development post COVID-19 pandemic

We summarise a recent report, published in Expert Opinion on Drug Discovery, that explored the challenges facing drug development processes […]

The value of AI in laboratory medicine

Here we summarise a recent article, published in American Journal of Clinical Pathology, that evaluated the thoughts of stakeholders in […]

Use of RWD for clinical trial conduct

We summarise a recent article, published in JAMIA, that reviewed the scope of database-specific RWD applications within clinical trial contexts. […]

Evaluation of data quality practices

Data quality is critical to avoid the ‘garbage in, garbage out’ paradigm. We summarise a recent systematic review, published in […]

RWD identifies target population for CAR-T therapy

We summarise a study, published in Pharmacoepidemiology and Drug Safety, that harnessed real–world data to define a reproducible procedure. This […]

Ten principles for data sharing and commercialisation

We summarise a recent article, published in JAMIA, that has provided a set of guidelines with ten key principles to […]

Barriers to adopting digital endpoints

The costs of drug R&D are rising. The ongoing COVID-19 has been a catalyst towards digitisation for many companies. Simultaneously, […]

The use and misuse of RWD during the pandemic

“The pandemic has brought out a lot of good, bad, and ugly.” – Cynthia Girman, Pharmaceutical Executive, Merck (on the […]

AI and automation across the pharmacovigilance lifecycle

Despite technological advancements within data capture, storage, linking and analysis, little attention has been paid to the impact of these […]

Pharma abandons antibiotics

Lack of financial incentive for antibiotics has led large pharmaceutical companies to leave the market. We summarise a recent article […]